KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 95 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,068,810 | -79.3% | 61,532 | -83.2% | 0.00% | -75.0% |
Q2 2023 | $5,167,008 | +225.2% | 366,975 | +148.5% | 0.01% | +166.7% |
Q1 2023 | $1,588,961 | -50.7% | 147,673 | -31.4% | 0.00% | -40.0% |
Q4 2022 | $3,222,482 | +1059.2% | 215,119 | +890.6% | 0.01% | – |
Q3 2022 | $278,000 | +33.0% | 21,715 | +0.4% | 0.00% | – |
Q2 2022 | $209,000 | -3.7% | 21,636 | -1.0% | 0.00% | – |
Q1 2022 | $217,000 | -16.5% | 21,858 | -1.2% | 0.00% | – |
Q4 2021 | $260,000 | – | 22,126 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 2,474,561 | $42,983,125 | 5.17% |
Rubric Capital Management LP | 3,077,449 | $53,455,289 | 2.00% |
Parkman Healthcare Partners LLC | 509,810 | $8,855,400 | 1.62% |
TANG CAPITAL MANAGEMENT LLC | 600,000 | $10,422,000 | 1.47% |
AlphaCentric Advisors LLC | 110,000 | $1,910,700 | 1.08% |
Lion Point Capital, LP | 130,691 | $2,270,103 | 1.01% |
RICE HALL JAMES & ASSOCIATES, LLC | 650,366 | $11,296,857 | 0.72% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 185,853 | $3,228,267 | 0.53% |
ADVISORY RESEARCH INC | 204,098 | $3,545,182 | 0.49% |
Jackson Creek Investment Advisors LLC | 65,607 | $1,140 | 0.48% |